Organogenesis

metrics 2024

Exploring the Pathways of Regeneration and Growth.

Introduction

Organogenesis is a leading journal published by Taylor & Francis Inc, dedicated to advancing the field of developmental biology and regenerative medicine. With an ISSN of 1547-6278 and E-ISSN 1555-8592, this journal spans an extensive research scope that includes embryology, transplantation, and biomedical engineering, distinguishing itself as a crucial platform for researchers and practitioners alike. Its impact is reflected in its performance across various categories in 2023, earning Q3 rankings in Biomedical Engineering and Embryology, Q4 in Developmental Biology, and Q2 in Transplantation, showcasing its reputable standing among peer journals. Moreover, with Scopus rankings indicating strong positioning in the fields of medicine and biochemistry, Organogenesis is essential for those looking to publish or stay updated on pioneering research. The journal facilitates rigorous peer-review and offers a forum for disseminating innovative findings, making it an invaluable resource for academics, professionals, and students committed to understanding the complexities of organism development.

Metrics 2024

SCIMAGO Journal Rank0.46
Journal Impact Factor1.60
Journal Impact Factor (5 years)2.50
H-Index61
Journal IF Without Self1.60
Eigen Factor0.00
Normal Eigen Factor0.04
Influence0.51
Immediacy Index0.80
Cited Half Life11.20
Citing Half Life5.80
JCI0.42
Total Documents388
WOS Total Citations1113
SCIMAGO Total Citations2841
SCIMAGO SELF Citations37
Scopus Journal Rank0.46
Cites / Document (2 Years)2.05
Cites / Document (3 Years)2.43
Cites / Document (4 Years)2.29

Metrics History

Rank 2024

Scopus

Embryology in Medicine
Rank #7/21
Percentile 66.67
Quartile Q2
Transplantation in Medicine
Rank #19/54
Percentile 64.81
Quartile Q2
Biomedical Engineering in Engineering
Rank #170/303
Percentile 43.89
Quartile Q3
Developmental Biology in Biochemistry, Genetics and Molecular Biology
Rank #50/82
Percentile 39.02
Quartile Q3

IF (Web Of Science)

BIOCHEMISTRY & MOLECULAR BIOLOGY
Rank 268/313
Percentile 14.50
Quartile Q4
DEVELOPMENTAL BIOLOGY
Rank 30/39
Percentile 24.40
Quartile Q4
ENGINEERING, BIOMEDICAL
Rank 95/122
Percentile 22.50
Quartile Q4

JCI (Web Of Science)

BIOCHEMISTRY & MOLECULAR BIOLOGY
Rank 253/313
Percentile 19.17
Quartile Q4
DEVELOPMENTAL BIOLOGY
Rank 31/39
Percentile 20.51
Quartile Q4
ENGINEERING, BIOMEDICAL
Rank 86/122
Percentile 29.51
Quartile Q3

Quartile History

Similar Journals

International Journal of Stem Cells

Illuminating the Path to Stem Cell Advancements
Publisher: KOREAN SOC STEM CELL RESEARCHISSN: 2005-3606Frequency: 2 issues/year

The International Journal of Stem Cells is a distinguished peer-reviewed journal dedicated to advancing the field of stem cell research. Published by the Korean Society for Stem Cell Research, this journal has established itself as a vital source of high-quality research since its inception in 2008. Operating under the ISSN 2005-3606 and E-ISSN 2005-5447, the journal caters to a global audience, featuring works that span a diverse array of topics within Cell Biology and Developmental Biology. It is noteworthy that as of 2023, the journal is ranked Q3 in Cell Biology and Q2 in Developmental Biology, highlighting its growing influence and credibility in the scientific community. Given its commitment to facilitating open scientific communication, it is crucial for researchers, professionals, and students to engage with the rigorous research published in this journal as it profoundly impacts the understanding and application of stem cell science. With accessibility to a wealth of innovative studies, the International Journal of Stem Cells remains an indispensable resource for anyone interested in the transformative potential of stem cell research.

Regenerative Therapy

Transforming discoveries into impactful solutions in regenerative medicine.
Publisher: ELSEVIERISSN: 2352-3204Frequency:

Regenerative Therapy is a premier open-access journal dedicated to advancing the fields of biomaterials, biomedical engineering, and developmental biology. Published by Elsevier in Japan, this journal has been an influential platform since its inception in 2015, contributing significantly to the global discourse on regenerative medicine. With an impressive Q2 ranking in major categories such as Biomaterials and Biomedical Engineering, it is recognized for its quality of research and innovation. Researchers seeking to disseminate their findings or explore cutting-edge developments will find Regenerative Therapy to be invaluable, reflecting current trends and fostering collaborations across interdisciplinary boundaries. The journal offers open access, ensuring that high-quality research is available to a broad audience and enhances the impact of scholarly work in the regenerative medicine community.

TISSUE & CELL

Fostering Excellence in Biological Sciences
Publisher: CHURCHILL LIVINGSTONEISSN: 0040-8166Frequency: 6 issues/year

TISSUE & CELL is a prominent academic journal, published by CHURCHILL LIVINGSTONE, that has been at the forefront of research in the fields of cell biology, developmental biology, and miscellaneous areas of medicine since its inception in 1969. With a strong focus on high-quality research, TISSUE & CELL has established itself within the academic community, holding a Q3 ranking in both Cell Biology and Developmental Biology, and a Q2 ranking in Medicine as of 2023. The journal aims to disseminate significant findings that contribute to the understanding of tissue structure and function, helping to bridge the gap between basic biological research and clinical applications. While it operates on a subscription basis and does not currently offer Open Access options, the journal remains a vital resource for researchers, professionals, and students interested in cutting-edge developments in the biological sciences. The journal's address is located in the scenic city of Edinburgh, further establishing its academic heritage in the United Kingdom.

Regenerative Engineering and Translational Medicine

Transforming Research into Real-World Solutions
Publisher: SPRINGER HEIDELBERGISSN: 2364-4133Frequency: 4 issues/year

Regenerative Engineering and Translational Medicine is an esteemed academic journal published by Springer Heidelberg, focusing on the interdisciplinary fields of biomaterials, biomedical engineering, and cell biology. With an ISSN of 2364-4133 and an E-ISSN of 2364-4141, the journal has carved a niche for itself since its inception in 2015, showcasing cutting-edge research that bridges the gap between scientific findings and practical applications in regenerative medicine. As a recognized platform in its field, it is currently positioned within Q3 quartiles in biomaterials, biomedical engineering, and medicine (miscellaneous), with a Scopus ranking that reflects its growing influence among peers. The journal aims to disseminate high-quality, peer-reviewed articles that highlight advancements in regenerative engineering, further advancing both theoretical and applied research. Scholars and practitioners seeking to stay at the forefront of the ever-evolving landscape of regenerative health solutions will find invaluable insights and innovations within these pages. Join a community of leading thinkers and explore the journal's comprehensive research contributions, which are crucial for fostering partnerships between academia and industry in the quest for transformative medical solutions.

IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL

Elevating the Study of In Vitro Dynamics
Publisher: SPRINGERISSN: 1071-2690Frequency: 10 issues/year

IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, published by SPRINGER, is a pivotal journal in the fields of cell biology and developmental biology, focusing on in vitro studies that enhance our understanding of animal cellular mechanisms and development. With an ISSN of 1071-2690 and an E-ISSN of 1543-706X, this esteemed journal offers a platform for researchers to present their findings and contribute to the body of knowledge necessary for advancements in biological sciences. As a recognized publication, it holds a 2023 category quartile of Q4 in Cell Biology and Developmental Biology, and Q3 in miscellaneous Medicine, reflecting its competitive position yet inviting critical submissions that can span multidisciplinary approaches. Though currently not open access, it serves as an essential resource for professionals, researchers, and students dedicated to unraveling the complexities of cellular processes in an ever-evolving field. The journal has been continuously published since 1986, signifying its long-standing commitment to fostering scientific discourse and innovation.

DNA AND CELL BIOLOGY

Advancing Knowledge in Cell and Genetic Sciences
Publisher: MARY ANN LIEBERT, INCISSN: 1044-5498Frequency: 12 issues/year

DNA AND CELL BIOLOGY, published by Mary Ann Liebert, Inc, is a distinguished journal in the realms of cell biology, genetics, and molecular biology, holding a notable position in its Q3 and Q2 quartile rankings across multiple academic categories as of 2023. With an ISSN of 1044-5498 and an E-ISSN of 1557-7430, this journal has been a pivotal platform for the dissemination of cutting-edge research since its inception in 1990, extending its coverage through 2024. Situated in the United States, the journal offers high-quality peer-reviewed articles, exploring significant advancements in biological sciences while fostering interdisciplinary collaborations within the research community. Though it currently does not offer open access, subscribed institutions and individual readers benefit from its rich repository of knowledge. The journal's rigorous standards and impactful content make it an essential resource for researchers, professionals, and students alike, aiming to stay at the forefront of discoveries influencing DNA and cellular dynamics.

STEM CELLS

Exploring breakthroughs in cell and developmental biology.
Publisher: OXFORD UNIV PRESSISSN: 1066-5099Frequency: 12 issues/year

STEM CELLS, published by Oxford University Press, is a leading academic journal dedicated to advancing the field of cell and developmental biology. With an impressive impact factor and ranking in the Q1 and Q2 quartiles across various disciplines, including Developmental Biology and Molecular Medicine, this journal serves as a critical platform for disseminating cutting-edge research findings from 1981 to the present. The journal's rigorous peer-review process ensures the highest quality of published content, making it an essential resource for researchers, healthcare professionals, and students interested in the latest breakthroughs in stem cell research and its applications. With a focus on innovative methodologies and holistic perspectives, STEM CELLS not only highlights significant discoveries but also fosters a collaborative exchange of ideas, driving forward the frontiers of science in regenerative medicine and developmental studies.

INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY

Advancing the Frontiers of Developmental Biology
Publisher: UNIV BASQUE COUNTRY UPV-EHU PRESSISSN: 0214-6282Frequency: 12 issues/year

The International Journal of Developmental Biology, published by the University of Basque Country UPV-EHU Press, has been a pivotal resource in the field of developmental biology since its inception in 1989. With an ISSN of 0214-6282 and an E-ISSN of 1696-3547, this journal serves as a platform for groundbreaking research and exploration within the realms of embryology and developmental biology. Although currently classified in the Q4 category for Developmental Biology and Q3 in Embryology as of 2023, the journal continues to provide vital insights that influence contemporary scientific understanding and practices. It ranks 14th out of 21 in the field of Embryology and holds a 35th percentile ranking in this specialized domain, emphasizing its emerging relevance in the academic community. Researchers, professionals, and students alike are encouraged to utilize the journal’s content to enrich their knowledge and drive innovation within developmental sciences. With an eye towards future developments, the journal anticipates continued evolution through the years, maintaining its commitment to high-quality, impactful research.

Russian Journal of Developmental Biology

Charting the course of developmental discovery.
Publisher: PLEIADES PUBLISHING INCISSN: 1062-3604Frequency: 6 issues/year

The Russian Journal of Developmental Biology, published by PLEIADES PUBLISHING INC, serves as a significant platform for researchers and professionals engaged in the field of developmental biology. With the ISSN 1062-3604 and E-ISSN 1608-3326, this journal focused on intricate biological processes and dynamic developmental mechanisms from 2005 until 2017. Although its coverage is currently discontinued in Scopus, it remains notable for its contribution to understanding the pivotal roles of biochemistry and molecular genetics within the context of development. As a publication situated in the competitive quartiles of the field and boasting an influential Scopus rank of #77 out of #78, it has made a unique mark in developmental studies. Researchers and academics seeking to enhance their knowledge of historical advancements in the discipline will find the journal a valuable resource, even as it navigates the transition away from active publication.

Journal of Stem Cells & Regenerative Medicine

Empowering Discoveries in Regenerative Medicine
Publisher: JOURNAL STEM CELLS & REGENERATIVE MEDICINEISSN: 0973-7154Frequency: 2 issues/year

The Journal of Stem Cells & Regenerative Medicine is a leading publication dedicated to the advancing field of stem cell research and regenerative medicine. Established in India and published by JOURNAL STEM CELLS & REGENERATIVE MEDICINE, this Open Access journal has been available since 2007, providing researchers and practitioners with free and unrestricted access to high-quality articles. With an ISSN of 0973-7154, the journal is indexed in Scopus, featuring a wide array of topics and insights into biochemistry, biotechnology, cell biology, and molecular biology, as denoted by its relevant quartile rankings. This journal is committed to bridging the gap between laboratory research and clinical applications, making significant contributions to the scientific community. The convergence of innovative studies from 2010 to 2024 positions it as an invaluable resource for those looking to stay at the forefront of stem cell and regenerative medicine research.